ABT-263: A Potent and Orally Bioavailable Bcl-2 Family InhibitorChristin Tse, Steven W. Elmore, Stephen W. Fesik et al.|Cancer Research|2008Cited by 2k
ABC transporters: the power to changeDouglas C. Rees, Oded Lewinson, Eric F. Johnson|Nature Reviews Molecular Cell Biology|2009Cited by 1.4k
ABT-888, an Orally Active Poly(ADP-Ribose) Polymerase Inhibitor that Potentiates DNA-Damaging Agents in Preclinical Tumor ModelsCherrie K. Donawho, David J. Frost, Yan Luo et al.|Clinical Cancer Research|2007Cited by 770
Potent and selective inhibitors of Akt kinases slow the progress of tumors <i>in vivo</i>Yan Luo, Vincent L. Giranda, Alexander R. Shoemaker et al.|Molecular Cancer Therapeutics|2005Cited by 244
Genistein, Resveratrol, and 5-Aminoimidazole-4-carboxamide-1-β-d-ribofuranoside Induce Cytochrome P450 4F2 Expression through an AMP-Activated Protein Kinase-Dependent PathwayMei‐Hui Hsu, Eric F. Johnson|Journal of Pharmacology and Experimental Therapeutics|2011Cited by 45